Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorfequiline, Pretomanid and Linezolid in Drug-sensitive Pulmonary Tuberculosis
NCT07672405Phase 2Recruiting
- Sponsor
- TB Alliance
- Start
- Jul 2026
- Primary completion
- May 2027
- Countries
- 2
01
Overview
A Phase 2 trial of sorfequiline in pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Jul 2026; status: recruiting.
02
Drugs
sorfequiline
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT07672405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07672405.